Company intelligence / Profile preview

Iprasense

Clapiers, Occitanie, France

Ownership: Private
Employees: ~4
Development stage: Other

Overview

Iprasense manufactures automated cell counting, viability analysis, and live cell imaging instruments for research and biopharmaceutical manufacturing. The company's NORMA 4S cell analyzer was used in the iConsensus project to measure cell density and viability in bioreactors

Modalities: Device
Industry: Pathology

Partnerships

European Union iConsensus project (collaborative development with Bayer, GSK, Pfizer, Sanofi, and academic institutions)Partnership with Conveyxo for exosome production platform

Beyond the preview

Go deeper on Iprasense.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Iprasense.

Explore the full profile